Related Experiment Videos
Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance
1Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, USA. sycheng@helix.nih.gov
Trends in Endocrinology and Metabolism: TEM
|April 30, 2005
Summary
Thyroid hormone receptors (TRs) are crucial for T3 activity. Novel mutations in TRbeta and TRalpha genes cause distinct thyroid hormone resistance syndromes, offering new insights into receptor-related diseases.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Thyroid hormone receptors (TRs) are transcription factors mediating thyroid hormone (T3) effects.
- Two THR genes (THR A and THR B) produce four T3-binding isoforms with conserved domains.
- Mutations in THRB cause thyroid hormone resistance (RTH).
Purpose of the Study:
- To investigate the role of novel change-of-function mutations in TRbeta in RTH pathogenesis.
- To explore recent findings on THRA gene mutations and their effects.
- To understand the distinct phenotypic manifestations of mutated THRB and THRA, highlighting isoform-dependent actions.
Main Methods:
- Comprehensive genomic profiling to identify novel mutations.
- Analysis of mutations in TRbeta and TRalpha genes.
- Comparison of phenotypic manifestations resulting from distinct TR mutations.
Main Results:
- Novel change-of-function mutations in TRbeta contribute to RTH.
- Abnormalities associated with THRA gene mutations have been identified.
- Mutated THRB and THRA genes exhibit distinct phenotypic effects in vivo.
Conclusions:
- Mutant TRs, particularly those in TRbeta and TRalpha, provide a new model for understanding RTH.
- The distinct clinical presentations underscore the isoform-specific roles of TR mutants.
- These findings advance the molecular understanding of thyroid hormone receptor-related diseases.